{"transactions":[{"id":1645860,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F8","text":"Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":6880,"derivative":{"exercise_price":0.59,"exercise_date":"2023-11-21","expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1645859,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F8","text":"Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":0.59,"exercise_date":"2023-11-21","expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1645858,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":9580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F7","text":"Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":9580,"derivative":{"exercise_price":1.6,"exercise_date":"2023-06-11","expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":9580},"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1645857,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":9580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F7","text":"Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":1.6,"exercise_date":"2023-06-11","expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":9580},"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1645856,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1645855,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":6980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6980},"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1645854,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on November 21, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":12862,"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1645853,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-13T20:08:45.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":6980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":7042,"source":{"system":"sec-edgar","filing":"0001493152-24-006047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006047/ownership.xml","form_type":"4"}},{"id":1730210,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-11-24T21:00:05.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":6880,"derivative":{"exercise_price":0.59,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-23-042659","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042659/ownership.xml","form_type":"4"}},{"id":1730209,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-11-24T21:00:05.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A."}],"balance_after":5820,"derivative":{"underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001493152-23-042659","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042659/ownership.xml","form_type":"4"}},{"id":1857108,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-06-13T22:44:11.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":9580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":9580,"derivative":{"exercise_price":1.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":9580},"source":{"system":"sec-edgar","filing":"0001493152-23-021128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223021128/ownership.xml","form_type":"4"}},{"id":1857107,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T22:44:11.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":6980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A"}],"balance_after":6980,"derivative":{"underlying":"Common Stock","underlying_shares":6980},"source":{"system":"sec-edgar","filing":"0001493152-23-021128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223021128/ownership.xml","form_type":"4"}},{"id":2221596,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T16:30:26.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2022 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 23, 2023 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":0.4561,"exercise_date":"2023-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-22-006939","document":"form4-06272022_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922006939/form4-06272022_040607.xml","form_type":"4"}},{"id":2404151,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-10T23:07:36.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":48340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period."}],"balance_after":48340,"derivative":{"exercise_price":2.32,"expiration_date":"2032-11-17","underlying":"Common Stock","underlying_shares":48340},"source":{"system":"sec-edgar","filing":"0001209191-22-008565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919122008565/doc4.xml","form_type":"4"}},{"id":2674654,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T17:05:43.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2021 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 8, 2022 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":1.31,"exercise_date":"2022-06-08","expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-21-002916","document":"form4-06102021_050612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921002916/form4-06102021_050612.xml","form_type":"4"}},{"id":2739506,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-26T23:52:40.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."},{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001171843-21-002776","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184321002776/ownership.xml","form_type":"4"}},{"id":3143935,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T18:54:40.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2020 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on May 12, 2021 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":1.97,"exercise_date":"2021-05-12","expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-20-006345","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020006345/edgar.xml","form_type":"4"}},{"id":3180645,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-07T21:32:41.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21."},{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001171843-20-002464","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184320002464/ownership.xml","form_type":"4"}},{"id":3394286,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Option","published_at":"2019-10-11T23:25:30.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":10106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."},{"field":"security","element":"securityTitle","label":"F3","text":"This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019."},{"field":"shares","element":"transactionShares","label":"F3","text":"This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."}],"balance_after":10106,"derivative":{"exercise_price":6.002,"exercise_date":"2019-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":10106},"source":{"system":"sec-edgar","filing":"0001171843-19-006481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184319006481/ownership.xml","form_type":"4/A","original_submission_date":"2019-07-03"}},{"id":3467752,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Option","published_at":"2019-07-03T21:33:20.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":187510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20."}],"balance_after":187510,"derivative":{"exercise_price":0.3001,"exercise_date":"2019-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":187510},"source":{"system":"sec-edgar","filing":"0001171843-19-004415","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184319004415/ownership.xml","form_type":"4"}},{"id":3499523,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T16:03:48.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2019 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 4, 2020 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":2.57,"exercise_date":"2020-06-04","expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-19-007275","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019007275/edgar.xml","form_type":"4"}},{"id":3558882,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-10T17:36:31.000Z","date":"2019-04-08","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted under the Issuer's 2013 Stock Incentive Plan. The option vests and becomes exercisable over a three-year period commencing on April 8, 2019. Thirty-three percent (33%) of the underlying shares vest and become exercisable on April 8, 2020 (first anniversary of the date of grant) with the balance of the underlying shares vesting in eight equal quarterly installments over the remaining two years of the three-year period, subject to continued service with the Issuer. The option automatically becomes exercisable in full upon the occurrence of a change in control of the Issuer."}],"balance_after":23000,"derivative":{"exercise_price":2.66,"expiration_date":"2029-04-08","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001179110-19-004897","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019004897/edgar.xml","form_type":"4"}},{"id":3844027,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:29:25.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":36109,"price":11.5,"value":415253.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") among Catalent Pharma Solutions, Inc., Catalent Boston, Inc. and Juniper Pharmaceuticals Inc. (the \"Issuer\") dated as of July 2, 2018.  At the effective time of the merger (the \"Effective Time\") as contemplated in the Merger Agreement, each share of outstanding Issuer common stock (other than appraisal shares and certain other shares), and each outstanding and unexercised Issuer stock option (whether vested or unvested) and each outstanding unvested restricted stock unit, immediately prior to the Effective Time were cancelled in exchange for $11.50 per share, net in cash, without interest, less any applicable taxes and applicable exercise price for the stock option (the \"Offer Price\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 8,910 restricted stock units that did not vest prior to the Effective Time of the merger.  Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unvested 8,910 restricted stock units was cancelled in exchange for the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-046804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046804/doc4.xml","form_type":"4"}},{"id":3872497,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Option","published_at":"2018-07-05T20:50:48.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":59660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19."}],"balance_after":59660,"derivative":{"exercise_price":1.11,"exercise_date":"2018-07-02","expiration_date":"2028-07-02","underlying":"Common Stock","underlying_shares":59660},"source":{"system":"sec-edgar","filing":"0001171843-18-005067","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184318005067/formfour.xml","form_type":"4"}},{"id":4266243,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":94366,"kind":"person","name":"Csimma Cristina","position":1,"cik":"0001501623","reported_name":"Csimma Cristina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2017-07-05T17:49:23.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":8910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock unit award shall vest in full immediately prior to the 2018 annual shareholders meeting."}],"balance_after":36109,"source":{"system":"sec-edgar","filing":"0001209191-17-043437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919117043437/doc4.xml","form_type":"4"}}]}